H.R. 1051 · 119TH CONGRESS

To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.

IntroducedHealth

This has not become law. Both chambers must pass the same text before sending it to the president. How a bill becomes law.

SPONSORSHIP

Sponsors & cosponsors.

Members who withdrew their support and later rejoined appear twice, with dates for each period.

PRIMARY SPONSOR

Joined Feb 6, 2025